These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 36948344)

  • 1. Biomedical applications of aptamer-modified chitosan nanomaterials: An updated review.
    Fathi-Karkan S; Mirinejad S; Ulucan-Karnak F; Mukhtar M; Ghahramani Almanghadim H; Sargazi S; Rahdar A; Díez-Pascual AM
    Int J Biol Macromol; 2023 May; 238():124103. PubMed ID: 36948344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biosensors based on aptamer-conjugated gold nanoparticles: A review.
    Nooranian S; Mohammadinejad A; Mohajeri T; Aleyaghoob G; Kazemi Oskuee R
    Biotechnol Appl Biochem; 2022 Aug; 69(4):1517-1534. PubMed ID: 34269486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MUC1 aptamer conjugated to chitosan nanoparticles, an efficient targeted carrier designed for anticancer SN38 delivery.
    Sayari E; Dinarvand M; Amini M; Azhdarzadeh M; Mollarazi E; Ghasemi Z; Atyabi F
    Int J Pharm; 2014 Oct; 473(1-2):304-15. PubMed ID: 24905777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-specific aptamers and their conjugation with nanomaterials for targeted drug delivery.
    Liao J; Liu B; Liu J; Zhang J; Chen K; Liu H
    Expert Opin Drug Deliv; 2015 Mar; 12(3):493-506. PubMed ID: 25430795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-linked chitosan/thiolated graphene quantum dots as a biocompatible polysaccharide towards aptamer immobilization.
    Mirzaie A; Hasanzadeh M; Jouyban A
    Int J Biol Macromol; 2019 Feb; 123():1091-1105. PubMed ID: 30458193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent progressions in biomedical and pharmaceutical applications of chitosan nanoparticles: A comprehensive review.
    Khalaf EM; Abood NA; Atta RZ; Ramírez-Coronel AA; Alazragi R; Parra RMR; Abed OH; Abosaooda M; Jalil AT; Mustafa YF; Narmani A; Farhood B
    Int J Biol Macromol; 2023 Mar; 231():123354. PubMed ID: 36681228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation on novel chitosan nanoparticle-aptamer complexes targeting TGF-β receptor II.
    Chen X; Zhu X; Li L; Xian G; Wang W; Ma D; Xie L
    Int J Pharm; 2013 Nov; 456(2):499-507. PubMed ID: 23999222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aptamer-Based Targeted Drug Delivery Systems: Current Potential and Challenges.
    He F; Wen N; Xiao D; Yan J; Xiong H; Cai S; Liu Z; Liu Y
    Curr Med Chem; 2020; 27(13):2189-2219. PubMed ID: 30295183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Mucin1 Aptamer-Conjugated Chitosan Nanoparticles for Targeted Co-Delivery of Docetaxel and IGF-1R siRNA to SKBR3 Metastatic Breast Cancer Cells.
    Jafari R; Majidi Zolbanin N; Majidi J; Atyabi F; Yousefi M; Jadidi-Niaragh F; Aghebati-Maleki L; Shanehbandi D; Soltani Zangbar MS; Rafatpanah H
    Iran Biomed J; 2019 Jan; 23(1):21-33. PubMed ID: 30041514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan-modified PLGA nanoparticles tagged with 5TR1 aptamer for in vivo tumor-targeted drug delivery.
    Taghavi S; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM
    Cancer Lett; 2017 Aug; 400():1-8. PubMed ID: 28412238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aptamer-conjugated PLGA nanoparticles for delivery and imaging of cancer therapeutic drugs.
    Hashemi M; Shamshiri A; Saeedi M; Tayebi L; Yazdian-Robati R
    Arch Biochem Biophys; 2020 Sep; 691():108485. PubMed ID: 32712288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aptamer-conjugated nanomaterials for bioanalysis and biotechnology applications.
    Chen T; Shukoor MI; Chen Y; Yuan Q; Zhu Z; Zhao Z; Gulbakan B; Tan W
    Nanoscale; 2011 Feb; 3(2):546-56. PubMed ID: 21109879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aptamer-assembled nanomaterials for biosensing and biomedical applications.
    Kong RM; Zhang XB; Chen Z; Tan W
    Small; 2011 Sep; 7(17):2428-36. PubMed ID: 21726041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimized aptamer functionalization for enhanced anticancer efficiency in vivo.
    Jiang MC; Liu HB; Wang JQ; Li S; Zheng Z; Wang D; Wei H; Yu CY
    Int J Pharm; 2022 Nov; 628():122330. PubMed ID: 36283643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances of chitosan-based nanoparticles for biomedical and biotechnological applications.
    Gao Y; Wu Y
    Int J Biol Macromol; 2022 Apr; 203():379-388. PubMed ID: 35104473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conjugation approaches for construction of aptamer-modified nanoparticles for application in imaging.
    Lee JH
    Curr Top Med Chem; 2013; 13(4):504-12. PubMed ID: 23432012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric aptamers in cancer cell-targeted drug delivery.
    Kanwar JR; Roy K; Kanwar RK
    Crit Rev Biochem Mol Biol; 2011 Dec; 46(6):459-77. PubMed ID: 21955150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unraveling the Effect of Breast Cancer Patients' Plasma on the Targeting Ability of Folic Acid-Modified Chitosan Nanoparticles.
    Nemati M; Bani F; Sepasi T; Zamiri RE; Rasmi Y; Kahroba H; Rahbarghazi R; Sadeghi MR; Wang Y; Zarebkohan A; Gao H
    Mol Pharm; 2021 Dec; 18(12):4341-4353. PubMed ID: 34779630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered Aptamer-Organic Amphiphile Self-Assemblies for Biomedical Applications: Progress and Challenges.
    Xiong H; Liu L; Wang Y; Jiang H; Wang X
    Small; 2022 Jan; 18(4):e2104341. PubMed ID: 34622570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent development of aptamer conjugated chitosan nanoparticles as cancer therapeutics.
    Sheikh A; Md S; Alhakamy NA; Kesharwani P
    Int J Pharm; 2022 May; 620():121751. PubMed ID: 35436511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.